Literature DB >> 15122315

HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function.

Valeria Di Stefano1, Giovanni Blandino, Ada Sacchi, Silvia Soddu, Gabriella D'Orazi.   

Abstract

The p53 oncosuppressor protein is subject to negative regulation by MDM2, which efficiently inhibits its activity through an autoregulatory loop. In response to stress, however, p53 undergoes post-translational modifications that allow the protein to escape MDM2 control, accumulate, and become active. Recent studies have shown that, following DNA damage, the HIPK2 serine/threonine kinase binds and phosphorylates p53, inducing p53 transcriptional activity and apoptotic function. Here, we investigated the role of HIPK2 in the activation of p53 in the presence of MDM2. We found that HIPK2 rescues p53 transcriptional activity overcoming MDM2 inhibition, and that restoration of this p53 function induces apoptosis. Recovery of p53-dependent apoptosis is achieved by preventing p53 nuclear export and ubiquitination mediated by MDM2 in vitro and in vivo following genotoxic stress. These results shed new light on the mechanisms by which the HIPK2/p53 pathway promotes apoptosis and suppression of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122315     DOI: 10.1038/sj.onc.1207656

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function.

Authors:  Isabelle Soubeyran; Isabelle Mahouche; Aude Grigoletto; Thierry Leste-Lasserre; Guillaume Drutel; Christophe Rey; Stephane Pedeboscq; France Blanchard; Veronique Brouste; Jean-Christophe Sabourin; Yves Bécouarn; Josy Reiffers; François Ichas; Francesca De Giorgi
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  The cancer-associated K351N mutation affects the ubiquitination and the translocation to mitochondria of p53 protein.

Authors:  Michela Muscolini; Elisa Montagni; Vanessa Palermo; Silvia Di Agostino; Wei Gu; Salma Abdelmoula-Souissi; Cristina Mazzoni; Giovanni Blandino; Loretta Tuosto
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

3.  Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2.

Authors:  Ekaterina Gresko; Ana Roscic; Stefanie Ritterhoff; Anton Vichalkovski; Giannino del Sal; M Lienhard Schmitz
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

4.  Expression patterns and action analysis of genes associated with hepatitis virus infection during rat liver regeneration.

Authors:  Li-Juan Su; Guang-Wei Ding; Zhi-Li Yang; Shou-Bing Zhang; Yu-Xiu Yang; Cun-Shuan Xu
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

5.  Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis.

Authors:  Barbara Cecchinelli; Luca Lavra; Cinzia Rinaldo; Stefano Iacovelli; Aymone Gurtner; Alessandra Gasbarri; Alessandra Ulivieri; Fabrizio Del Prete; Maria Trovato; Giulia Piaggio; Armando Bartolazzi; Silvia Soddu; Salvatore Sciacchitano
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

6.  HIPK2 inhibits cell metastasis and improves chemosensitivity in esophageal squamous cell carcinoma.

Authors:  Zhen Zhang; Penghai Wen; Fangfang Li; Chuanshan Yao; Tongfu Wang; Bing Liang; Qingle Yang; Lei Ma; Limin He
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.447

7.  Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals.

Authors:  Kyoichi Isono; Kazumi Nemoto; Yuanyuan Li; Yuki Takada; Rie Suzuki; Motoya Katsuki; Akira Nakagawara; Haruhiko Koseki
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Different functions of HIPK2 and CtBP2 in traumatic brain injury.

Authors:  Feihui Zou; Jian Xu; Hongran Fu; Jianhua Cao; Hui Mao; Mingjie Gong; Gang Cui; Yang Zhang; Wei Shi; Jian Chen
Journal:  J Mol Neurosci       Date:  2012-10-18       Impact factor: 3.444

9.  Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  J Proteome Res       Date:  2007-10-26       Impact factor: 4.466

10.  Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha.

Authors:  Lavinia Nardinocchi; Rosa Puca; Ada Sacchi; Gideon Rechavi; David Givol; Gabriella D'Orazi
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.